Indication

Chlamydial conjunctivitis

Chlamydial conjunctivitis is an infectious ocular inflammation caused by the obligate intracellular bacterium *Chlamydia trachomatis*, primarily serovars D through K. Read more about Chlamydial conjunctivitis

68 drugs 41 manufacturers

Advertisement

Drugs that treat it

Common Chlamydial conjunctivitis therapies.

Showing 55–63 of 68 drugs

Filter & compare in the drug finder →Opens the drug finder with Chlamydial conjunctivitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chlamydial conjunctivitis.

Chlamydial conjunctivitis is an infectious ocular inflammation caused by the obligate intracellular bacterium *Chlamydia trachomatis*, primarily serovars D through K.

It predominantly affects sexually active adolescents and adults via autoinoculation from genital secretions, as well as neonates exposed during passage through an infected birth canal.

Adult presentations are typically characterized by subacute or chronic unilateral or bilateral conjunctival hyperemia, mucopurulent discharge, prominent lymphoid follicles in the inferior fornix, and tender preauricular lymphadenopathy.

In neonates, it manifests within 5 to 14 days postpartum as papillary conjunctivitis, eyelid edema, and marked mucopurulent exudate, with potential progression to corneal pannus or conjunctival scarring if left untreated.

Personalize your experience

Follow Chlamydial conjunctivitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it